Ticker News
$HIVE News
Stored TradersLink news articles and press-release context for this ticker. Discord alerts link into these article pages when full article text is available.
Published Articles
Latest saved alerts
HIVE prices US$115M 0% exchangeable senior notes due 2031 (upsized)
HIVE priced US$115 million aggregate principal of 0% exchangeable senior notes due 2031 in a private Rule 144A offering by its Bermuda subsidiary, up from $100M, with an initial purchasers' option to buy up to an additional $15M. The notes are non‑interest bearing, guaranteed by HIVE, exchangeable at 206.9429 shares per $1,000 principal (initial exchange price ≈ $4.83) and the sale is expected to close on June 30, 2026. Estimated net proceeds are ~US$110.0M (≈US$124.5M if the option is exercised) and HIVE entered capped‑call hedges (cap $8.5275) whose hedging activity could involve purchases or sales of HIVE shares. Timing: The press release does not indicate dilution today; initial share dilution occurs at the offering close (Jun 30, 2026), and once the offering closes those shares have been issued.
HIVE inks LOI for up to 10-year HPC colocation at Boden to host up to 10,000 GB300 GPUs
HIVE signed a non-binding letter of intent with an investment-grade sovereign Swedish technology client for up to a 10-year lease of its 32 MW Boden facility, with Boden Municipal Council having approved HIVE's acquisition of the site. The LOI contemplates retrofitting the site to support roughly 25 MW of critical IT load (up to 10,000 GB300 GPUs, single-rack densities to 150 kW) using hybrid direct-to-chip liquid and air cooling, which management says could drive significant recurring revenue, but the deal, retrofit, timing and financial impacts remain subject to definitive agreements and execution risk.
HIVE's Paraguay A40 GPUs matched H100s in Columbia Univ study; paper sent to NeurIPS
HIVE reports Columbia University's IEOR team remotely ran iterative pretraining on HIVE A40 GPU nodes in Asunción and — after code optimizations and normalizing for raw hardware performance — found A40s matched H100 performance; the research has been submitted to NeurIPS. The company says this validates intercontinental AI training, provides baseline token/sec/latency metrics for its platform, and supports its Yguazú build-out (100 MW substation civil works complete, energization expected Sep 2026 and a Tier‑III data center targeted H2 2027).
HIVE's BUZZ HPC wins ~$220M, 3-year sovereign AI GPU contract with Bell/Cohere
HIVE's BUZZ HPC has signed a three-year GPU cloud contract worth approximately USD $220M to deploy 2,304 NVIDIA Grace Blackwell GPUs (GB200 NVL72 racks) at Bell's Merritt, BC facility to host Cohere's foundation models and enterprise AI for Canadian government and corporate customers; the deployment is expected to go live in late 2026 to early 2027. Management says the deal will strengthen HIVE/BUZZ's position in Canada's sovereign AI stack and is expected to add roughly $70M contracted ARR to the company's current ~$35M realized ARR, with part of the hardware purchase funded from HIVE's April 2026 USD $115M convertible note financing.
HIVE to acquire 32 MW Big Boden data center in Sweden, moves from tenant to owner
Boden Municipal Council approved HIVE's acquisition of the 32 MW Big Boden data center, converting the company from tenant to owner and securing long-term control of its Swedish campus. HIVE plans to upgrade the site toward Tier III standards to support enterprise AI/HPC (including NVIDIA GPUs), highlights ~960M SEK of prior local investment and continued community partnerships, and says the deal remains subject to customary closing conditions and execution risks.
Bell, Cohere, Hypertec & BUZZ (HIVE) form sovereign AI infrastructure partnership in Canada
Bell, Cohere, Hypertec and BUZZ HPC (a HIVE subsidiary) announced a commercial partnership to build a Canadian sovereign AI stack: Bell will provide data centre capacity at its Merritt, BC facility, BUZZ/HIVE will deliver the AI-native cloud and NVIDIA DSX-powered GPU clusters on Hypertec's Canadian-built hardware, and Cohere will operate its foundation models and enterprise AI services on the platform. The deal is positioned to target government and enterprise demand for production-grade, Canadian-located AI infrastructure and data sovereignty, though the release discloses no financial terms, capacity volumes or timelines.
Oncotelic (OTLC) and peers push nanoparticle/PK delivery platforms as a way to improve existing cancer drugs
An industry editorial highlights growing R&D and investor focus on advanced drug‑delivery technologies (nanoparticles, IV reformulations, precision PK) as a potentially faster, lower‑risk way to boost the performance of approved oncology drugs. It calls out Oncotelic Therapeutics (OTLC) advancing its Deciparticle platform, Sapu003 program and AI initiative PDAOAI and references similar platform moves at NWBO, SGMO, HIVE and IOVA, but provides no clinical outcome data or concrete regulatory/commercial milestones.